Most Read Articles
01 Oct 2015
BLACKMORES VITAMIN D3 – Vitamin D3 1,000 IU Capsules
15 Dec 2016
New drug applications approved by US FDA as of 1 - 15 December 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Kavitha G. Shekar, 21 Jun 2016

The American Diabetes Association’s (ADA) President Desmond Schatz challenged the scientific community to transform diabetes from an invisible disease to a highly visible crisis. “Diabetes is an epidemic spiralling out of control across this country and around the world, yet it remains largely invisible,” he said, speaking at the 76th Scientific Sessions of ADA in New Orleans, Louisiana, US.

31 Jul 2017
New drug applications approved by US FDA as of 16 - 31 July 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Retinal microvascular changes in pregnancy linked to postpartum glucose metabolism abnormalities

Roshini Claire Anthony
12 Oct 2017

Changes in retinal microvasculature during pregnancy may signify an increased risk of abnormal glucose metabolism 5 years later, according to a study of the GUSTO* population.

Researchers from the Singapore Eye Research Institute examined 276 pregnant women with singleton pregnancies from the GUSTO study who underwent retinal photography at week 26–28 gestation (baseline) and were assessed for glucose tolerance using a 75 g oral glucose tolerance test at baseline and 5 years postpartum. Of these, 142 women were diagnosed with gestational diabetes mellitus (GDM; fasting glucose ≥7.0 mmol/L and/or 2-hour glucose ≥7.8 mmol/L) at the baseline visit.

Abnormal glucose metabolism was defined as GDM in subsequent pregnancies within the 5-year follow-up period, prediabetes (impaired fasting glucose [fasting plasma glucose (FPG) 6.1–6.9 mmol/L], impaired glucose tolerance [FPG <7.0 mmol/L and 2-hour plasma glucose 7.9–11.0 mmol/L], or HbA1c 5.7–6.4 percent), or diabetes (FPG ≥7.0 mmol/L or 2-hour plasma glucose ≥11.0 mmol/L) diagnosed at 5 years.

About 25 percent of participants who had subsequent pregnancies had GDM (n=26) while 30.4 percent had abnormal glucose metabolism at 5 years postpartum (n=84).

After adjusting for maternal age, education, prepregnancy body mass index, ethnicity, and GDM at baseline, increases in retinal venular calibre at baseline were associated with an increased risk of abnormal glucose metabolism at 5 years postpartum (risk ratio [RR], 1.2, 95 percent confidence interval, 1.0–1.5; p<0.05 for every 10 µm widening in retinal venular calibre). [Diabetologia 2017;doi:10.1007/s00125-017-4441]

Narrowing of retinal arteriolar calibre and retinal venular branching angle were also associated with increased insulin resistance index at 5-year follow-up (HOMA-IR, 1.4 and 1.3 for every 10 µm and 10⁰ decrease, respectively; p<0.05).

The association between retinal microvascular changes during pregnancy and subsequent GDM was not significant.

“[I]t is postulated that abnormalities of the microvasculature signal subclinical pathophysiological changes prior to overt insulin resistance and hyperglycaemia,” said the researchers. “Retinal imaging provides a direct view of the retinal microvasculature that could be a proxy for the systemic microvascular structure,” they said.

“[I]n this cohort of mothers with and without GDM at baseline, altered retinal microvascular morphology … was associated with postpartum insulin resistance represented by fasting insulin level and insulin resistance index,” said the researchers.

“Our findings may … help to provide a potential novel and quantitative predictor … during pregnancy for identifying mothers who are at high risk of abnormal glucose metabolism after pregnancy or in subsequent pregnancies,” they said, recommending that future research assess these outcomes in a larger population and with a longer follow-up period.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Oct 2015
BLACKMORES VITAMIN D3 – Vitamin D3 1,000 IU Capsules
15 Dec 2016
New drug applications approved by US FDA as of 1 - 15 December 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Kavitha G. Shekar, 21 Jun 2016

The American Diabetes Association’s (ADA) President Desmond Schatz challenged the scientific community to transform diabetes from an invisible disease to a highly visible crisis. “Diabetes is an epidemic spiralling out of control across this country and around the world, yet it remains largely invisible,” he said, speaking at the 76th Scientific Sessions of ADA in New Orleans, Louisiana, US.

31 Jul 2017
New drug applications approved by US FDA as of 16 - 31 July 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.